Results 41 to 50 of about 210,637 (269)

Severe OHSS rate of GnRH long agonist protocol versus GnRH antagonist protocol per woman.

open access: yes, 2014
Severe OHSS rate of GnRH long agonist protocol versus GnRH antagonist protocol per woman.
Lin Li (28817)   +5 more
core   +1 more source

Tracking CDK1 Dynamics With a Novel Biosensor Mouse and Clinical Cohorts to Predict CDK4/6 Inhibitor Sensitivity in ER+ Breast Cancer

open access: yesAdvanced Science, EarlyView.
Cyclin‐dependent kinase (CDK) 1 activity is a dynamic marker of treatment response in estrogen receptor positive breast cancer. Patient cohorts reveal CDK1 activity increases during progression to invasive disease, where high expression correlates with poor survival. Using a novel Cdk1 biosensor mouse alongside in vitro models, we demonstrate that CDK1
Sarah Alexandrou   +17 more
wiley   +1 more source

Oral Recombinant Human Collagen III Protects Gastric Mucosa via G‐Quadruplex‐Mediated Activation of the Pla2g4a‐Prostaglandin Axis

open access: yesAdvanced Science, EarlyView.
Orally administered recombinant human type III collagen protects the gastric mucosa from ethanol‐induced injury by coordinating redox homeostasis, epithelial barrier repair, and arachidonic acid–prostaglandin metabolism. Gastric digestion releases the pentapeptide GPAEF, which interacts with the Pla2g4a promoter G‐quadruplex in a structure‐dependent ...
Xinyue Lan   +14 more
wiley   +1 more source

Stop gonadotropin-releasing hormone-agonist protocol not superior to antagonist protocol on the outcomes of assisted reproductive techniques in poor responders: A randomized clinical trial

open access: yesInternational Journal of Reproductive BioMedicine
Background: Poor ovarian response remains one of the most challenging problems in assisted reproductive technology. Various stimulation protocols have been proposed to improve outcomes, including combined gonadotropin-releasing hormone (GnRH) agonist ...
Saeideh Dashti   +4 more
doaj   +1 more source

Comparison of results of controlled ovarian stimulation (initiated cycles) for patients with AMH <1.2 ng/mL between the GnRH agonist (GnRH-a) and antagonist (GnRH-ant) protocols.

open access: yes, 2018
Comparison of results of controlled ovarian stimulation (initiated cycles) for patients with AMH
Ming-Chao Huang (798716)   +6 more
core   +1 more source

Peripheral administration of SB223412, a selective neurokinin-3 receptor antagonist, suppresses pulsatile luteinizing hormone secretion by acting on the gonadotropin-releasing hormone pulse generator in estrogen-treated ovariectomized female goats

open access: yesThe Journal of Reproduction and Development, 2020
Accumulating evidence suggests that KNDy neurons located in the hypothalamic arcuate nucleus (ARC), which are reported to express kisspeptin, neurokinin B, and dynorphin A, are indispensable for the gonadotropin-releasing hormone (GnRH) pulse generation ...
Takuya SASAKI   +14 more
doaj   +1 more source

GnRH antagonists in poor responders

open access: yesActa Obstetricia et Gynecologica Scandinavica, 2004
Acta Obstet Gynecol ...
Kolibianakis, Efstratios   +5 more
openaire   +4 more sources

Parametric Analysis of Spiking Neurons in 16 nm Fin Field‐Effect Transistor Technology

open access: yesAdvanced Intelligent Discovery, EarlyView.
Energy efficient computing has driven a shift toward brain‐inspired neuromorphic hardware. This study explores the design of three distinct silicon neuron topologies implemented in 16 nm fin field‐Effect transistor technology. While the Axon‐Hillock design achieves gigahertz throughput, its functional fragility persists. The Morris–Lecar model captures
Logan Larsh   +3 more
wiley   +1 more source

A Patient Friendly Corifollitropin Alfa Protocol without Routine Pituitary Suppression in Normal Responders. [PDF]

open access: yesPLoS ONE, 2016
The release of corifollitropin alfa simplifies daily injections of short-acting recombinant follicular stimulating hormone (rFSH), and its widely-used protocol involves short-acting gonadotropins supplements and a fixed GnRH antagonist regimen, largely ...
Huai-Ling Wang   +6 more
doaj   +1 more source

The Comparision Of Effect Of Microdose Gnrh-A Flare-Up, Gnrh Antagonist/Aromatase İnhibitor Letrozole And Gnrh Antagonist/Clomiphene Citrate Protocols On Ivf Outcomes İn Poor Responder Patients

open access: yes, 2014
Purpose: To compare the effects of microdose GnRH-a flare-up, GnRH antagonist/aromatase inhibitor letrozole and GnRH antagonist/clomiphene citrate protocols on IVF outcomes in poor responder patients.
Bostancı, Mehmet Sühha   +1 more
core   +1 more source

Home - About - Disclaimer - Privacy